# The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024, Regulation 141: Amendment to Schedule 17

Extent: E+W+S+N.I.

In Schedule 17 (exemption for sale, supply or administration by certain persons)—
(a) in the table in Part 1, in column 1 in entry 10, omit “EU marketing authorisations”;
(b) in the table in Part 4, in columns 1 and 2 in entry 9, omit “EU marketing authorisation”.

---
Source: https://www.legislation.gov.uk/uksi/2024/832/regulation/141 (the official version)
Page: https://openlegislation.uk/human-medicines-amendments-relating-to-the-windsor-framework-regulations-2024/regulation-141
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.